Publication: Activated protein C, severe sepsis and 28-day mortality.
dc.contributor.author | Torre-Prados, M de la | |
dc.contributor.author | García-de la Torre, A | |
dc.contributor.author | Nieto-González, M | |
dc.contributor.author | Lucena-González, I | |
dc.contributor.author | Escobar-Conesa, R | |
dc.contributor.author | García-Alcántara, A | |
dc.contributor.author | Enguix-Armada, A | |
dc.contributor.authoraffiliation | [Torre-Prados,M de la; García-de la Torre,A; Nieto-González,M; Lucena-González,I; Escobar-Conesa,R; García-Alcántara,A; Enguix-Armada,A] Hospital Universitario Virgen de la Victoria, Málaga, Spain. | es |
dc.date.accessioned | 2013-04-01T09:20:59Z | |
dc.date.available | 2013-04-01T09:20:59Z | |
dc.date.issued | 2012-05-20 | |
dc.description.abstract | Protein C (PC) de ciency is prevalent in severe sepsis, studies showing that more than 80% of patients with severe sepsis have a baseline PC level below the lower limit of normal [1,2]. The aim of the study was to relate the anticoagulation activity evaluated by PC, with clinical parameters and 28-day mortality. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Torre-Prados M de la., García-de la Torre A., Nieto-González M., Lucena-González I., Escobar-Conesa R., García-Alcántara A. et al. Activated protein C, severe sepsis and 28-day mortality. Critical Care. 2012;16(Suppl. 1):S8-S9 | es |
dc.identifier.doi | 10.1186/cc10630 | |
dc.identifier.essn | 1466-609X | |
dc.identifier.issn | 1364-8535 | |
dc.identifier.uri | http://hdl.handle.net/10668/866 | |
dc.journal.title | Critical Care | |
dc.language.iso | en | |
dc.publisher | BioMed Central | es |
dc.relation.publisherversion | http://ccforum.com/content/16/S1/P23 | es |
dc.rights.accessRights | open access | |
dc.subject | Deficiencia de Proteína C | es |
dc.subject | Coagulación Sanguínea | es |
dc.subject | Choque Séptico | es |
dc.subject | Proteina C | es |
dc.subject | Humanos | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Blood Coagulation Disorders::Blood Coagulation Disorders, Inherited::Protein C Deficiency | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Circulatory and Respiratory Physiological Phenomena::Blood Physiological Phenomena::Blood Physiological Processes::Hemostasis::Blood Coagulation | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Sepsis::Shock, Septic | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzyme Precursors::Protein C | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult | es |
dc.title | Activated protein C, severe sepsis and 28-day mortality. | es |
dc.type | conference presentation | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Torre_Activated.pdf
- Size:
- 65.95 KB
- Format:
- Adobe Portable Document Format
- Description:
- Abstract publicado